AZB & Partners advised Pfizer Inc. and its group entities on all Indian legal and regulatory aspects of the restructuring process, including advising on related compliance under Indian securities regulations and obtaining regulatory approvals from the Foreign Investment Promotion Board and the Reserve Bank of India. The transaction involves a restructuring undertaken by Pfizer Group to sell its animal health business worldwide, which, in India, included (i) acquisition by PAH Indian Holding B.V. Netherlands of 99.99% and by PAH India Holdco LLC, USA of 0.01% of Pfizer Pharmaceuticals India Private Limited, (ii) acquisition of the animal health business of Pfizer Limited by Pfizer Animal Pharma Private Limited, (iii) sale of equity of Pfizer Animal Pharma Private Limited by Pfizer Limited to Pfizer Pharmaceuticals India Private Limited and (iv) acquisition by Pfizer East India B.V., Netherlands of approximately 61% of Pfizer Limited from Pfizer Investments, Netherlands and Pfizer Corporation, Panama. The transaction was led by Srinath Dasari, Nanditha Gopal.

AZB & Partners advises Khopoli Investments Limited in relation to $205,000,000 syndicated loan Khopoli Investments Limited (subsidiary of Tata Power Company Limited) and The Tata Power Company Limited was advised by AZB & Partners in relation to $205,000,000 syndicated loan (“Facility”) availed by it from Australia and New Zealand Banking Group Limited, Bank of America, N.A. and The Royal Bank of Scotland plc. (“Lenders”) for refinancing of its existing term loans. The Facility is backed by a corporate guarantee issued by The Tata Power Company Limited. The firm plays as an Indian Counsel to Khopoli Investments Limited (the Borrower) and The Tata Power Company Limited (the Guarantor). The approximate consideration of the transaction is USD 205 million. The deal was led by Shameek Chaudhuri, Debashree Dutta.